Cargando…
Melanoma Immunotherapy and Precision Medicine in the Era of Tumor Micro-Tissue Engineering: Where Are We Now and Where Are We Going?
SIMPLE SUMMARY: Melanoma is a cancer with very poor survival rates, although its treatment has been revolutionized by targeted therapy and immunotherapy. It is a complex disease, where dynamic interactions, not only among melanoma cells themselves, but also between tumor cells and their surroundings...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616100/ https://www.ncbi.nlm.nih.gov/pubmed/34830940 http://dx.doi.org/10.3390/cancers13225788 |